GASTROINTESTINAL DYSPLASIA

This adverse event was reported 121 times

These drugs are most commonly taken by patients reporting GASTROINTESTINAL DYSPLASIA:

# Drug Count
0 ADALIMUMAB 32
1 PANTOPRAZOLE 17
2 FUROSEMIDE 13
3 ALLOPURINOL 12
4 TORSEMIDE 12
5 CANDESARTAN CILEXETIL 11
6 OMEPRAZOLE 11
7 OMEPRAZOLE MAGNESIUM 11
8 SPIRONOLACTONE 11
9 DEXAMETHASONE 10
See all common drugs associated with GASTROINTESTINAL DYSPLASIA

GASTROINTESTINAL DYSPLASIA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MEPIVACAINE HYDROCHLORIDE 9 0.0078
1 PANTHENOL 1 0.0034
2 VERAPAMIL HYDROCHLORIDE 9 0.0021
3 PIROXICAM 9 0.0014
4 PSYLLIUM HUSK 1 0.0007
5 CANDESARTAN CILEXETIL 11 0.0004
6 NEOMYCIN OINTMENT 1 0.0004
7 RITUXIMAB-ABBS 2 0.0004
8 TORSEMIDE 12 0.0004
9 AMIODARONE HYDROCHLORIDE 3 0.0003
See all drugs enriched for association with GASTROINTESTINAL DYSPLASIA

GASTROINTESTINAL DYSPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Guanylate Cyclase-C Agonist [EPC] 1 0.0005
1 General Anesthetic [EPC] 9 0.0002
2 Provitamin D2 Compound [EPC] 5 0.0002
3 Prostacyclin Receptor Agonist [EPC] 3 0.0001
4 Integrin Receptor Antagonist [EPC] 10 0.0001
5 Purine Antimetabolite [EPC] 8 0.0001
6 Aminosalicylate [EPC] 8 0.0001
7 GLP-2 Analog [EPC] 1 0.0001
8 Aldosterone Antagonist [EPC] 11 0.0001
9 Xanthine Oxidase Inhibitor [EPC] 12 0.0001
See all drug classes enriched for association with GASTROINTESTINAL DYSPLASIA